Compound class:
Synthetic organic
Comment: BWC0977 is an oxazolidinone class antibacterial claimed in patent WO2018225097A1 [1]. It has broad-spectrum antibacterial activity and is a type II DNA topoisomerase inhibitor with similar activity against DNA gyrase and DNA topoisomerase 4.
![]() Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
BWC0977 inhibits DNA gyrase and DNA topoisomerase 4 with equipotency and in both Gram-positive and Gram-negative bacterial species.The IC50 values provided in the table below where presented at the 29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2019: see poster #P1844). |
Selectivity at other protein targets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|